BHC Bausch Health Companies Inc

USD 10.49 0.63 6.389452
Icon

Bausch Health Companies Inc (BHC) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NYE
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 10.49

+0.63 (+6.39)%

USD 3.60B

6.34M

USD 10.66(+1.65%)

USD 11.00 (+4.86%)

Icon

BHC

Bausch Health Companies Inc (USD)
COMMON STOCK | NYE
USD 10.49
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 3.60B

USD 11.00 (+4.86%)

USD 10.49

Bausch Health Companies Inc (BHC) Stock Forecast

USD 10.66
(+1.65%)

Based on the Bausch Health Companies Inc stock forecast from 3 analysts, the average analyst target price for Bausch Health Companies Inc is USD 10.66 over the next 12 months. Bausch Health Companies Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Bausch Health Companies Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Bausch Health Companies Inc’s stock price was USD 10.49. Bausch Health Companies Inc’s stock price has changed by +9.38% over the past week, +14.27% over the past month and +40.43% over the last year.

No recent analyst target price found for Bausch Health Companies Inc
No recent average analyst rating found for Bausch Health Companies Inc

Company Overview Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, inter...Read More

2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8

20,270

December

USD

USA

Adjusted Closing Price for Bausch Health Companies Inc (BHC)

Loading...

Unadjusted Closing Price for Bausch Health Companies Inc (BHC)

Loading...

Share Trading Volume for Bausch Health Companies Inc Shares

Loading...

Compare Performance of Bausch Health Companies Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BHC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bausch Health Companies Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc +2.84 (+1.71%) USD79.01B 34.04 22.84

ETFs Containing BHC

Symbol Name BHC's Weight Expense Ratio Price(Change) Market Cap
EDOC
Global X Telemedicine & D.. 5.18 % 0.68 % +0.15 (+1.60%) USD0.05B

Frequently Asked Questions About Bausch Health Companies Inc (BHC) Stock

Based on ratings from 3 analysts Bausch Health Companies Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 2 hold ratings.

Unfortunately we do not have enough data on BHC's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for BHC is USD 10.66 over the next 12 months. The maximum analyst target price is USD 14 while the minimum anlayst target price is USD 8.99.

BHC stock's Price/Earning ratio is 71.75. Our analysis grades BHC stock's Price / Earning ratio at F. This means that BHC stock's Price/Earning ratio is above 67% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this BHC may be a overvalued for its sector.

The last closing price of BHC's stock was USD 10.49.

The most recent market capitalization for BHC is USD 3.60B.

Based on targets from 3 analysts, the average taret price for BHC is projected at USD 10.66 over the next 12 months. This means that BHC's stock price may go up by +1.65% over the next 12 months.

Following are ETFs with the highest allocation to Bausch Health Companies Inc's stock :

EDOC

As per our most recent records Bausch Health Companies Inc has 20,270 Employees.

Bausch Health Companies Inc's registered address is 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8. You can get more information about it from Bausch Health Companies Inc's website at https://www.bauschhealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...